Bruker Corp (FRA:BKD)
€ 59.28 1.32 (2.28%) Market Cap: 8.99 Bil Enterprise Value: 10.02 Bil PE Ratio: 23.53 PB Ratio: 6.64 GF Score: 95/100

Bruker Corp Investor Day Transcript

Jun 20, 2019 / 12:00PM GMT
Release Date Price: €42.17 (+0.45%)
Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Good morning, everyone. Pleasure to have you here at our Investor Day 2019. It's nice to see so many of you from the sell side. Of course, we've all known each other for quite some time now. And of course, many of you are also -- some of you are new here, and we haven't met yet. Many from the buy side as well.

We acknowledge NASDAQ providing this wonderful new facility to us. It's really an ideal setting for having this Investor Day. And just wanted to acknowledge that one of our Board members, Independent Directors and Chair of our Audit Committee, John Ornell, is here today to support us for moral support. And all difficult questions go to John.

So welcome again to our Investor Day. Just briefly like to draw your attention to -- that we issued a press release at 7:00 a.m. this morning not related to our Investor Day but to the American Society of Microbiology that we're kicking off -- the conference that's kicking off today in San Francisco, where we're launching additional MALDI Biotyper, a next-generation MALDI

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot